Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Goodwill (2022 - 2024)

Zentalis Pharmaceuticals (ZNTL) has 3 years of Goodwill data on record, last reported at $3.7 million in Q3 2024.

  • For Q3 2024, Goodwill changed 0.0% year-over-year to $3.7 million; the TTM value through Sep 2024 reached $3.7 million, changed 0.0%, while the annual FY2023 figure was $3.7 million, 0.0% changed from the prior year.
  • Goodwill reached $3.7 million in Q3 2024 per ZNTL's latest filing, roughly flat from $3.7 million in the prior quarter.
  • Across five years, Goodwill topped out at $3.7 million in Q1 2022 and bottomed at $3.7 million in Q1 2022.
  • Average Goodwill over 3 years is $3.7 million, with a median of $3.7 million recorded in 2022.
  • The widest YoY moves for Goodwill: up 0.0% in 2023, down 0.0% in 2023.
  • A 3-year view of Goodwill shows it stood at $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then changed by 0.0% to $3.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Goodwill were $3.7 million in Q3 2024, $3.7 million in Q2 2024, and $3.7 million in Q1 2024.